Bluejay Diagnostics (NASDAQ:BJDX) Posts Quarterly Earnings Results

Bluejay Diagnostics (NASDAQ:BJDX) issued its earnings results on Monday. The company reported ($112.37) earnings per share (EPS) for the quarter, Zacks reports.

Bluejay Diagnostics Stock Down 2.1 %

Shares of BJDX traded down $0.08 during mid-day trading on Monday, hitting $3.73. 13,512 shares of the company traded hands, compared to its average volume of 191,807. Bluejay Diagnostics has a 1-year low of $3.03 and a 1-year high of $323.68. The company has a market capitalization of $2.06 million, a PE ratio of 0.00 and a beta of 0.38. The business has a 50 day moving average of $3.83 and a 200 day moving average of $4.52.

Bluejay Diagnostics Company Profile

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.